helpfulRider22963

SPRO Final 3rd Testing Successful

ロング
NASDAQ:SPRO   Spero Therapeutics, Inc.
I bought this stock too early and watch it get clobbered. Then they announced their drug final 3rd stage testing was successful. This company is a $30 stock but they still have to raise money and go to market. BUT this guarantees they will be successful.
免責事項

これらの情報および投稿は、TradingViewが提供または保証する金融、投資、取引、またはその他の種類のアドバイスや推奨を意図したものではなく、またそのようなものでもありません。詳しくは利用規約をご覧ください。